Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Blood
|
August 25, 2012
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Blood
|
May 12, 2009
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
Claudia Haferlach, Cristina Mecucci, Susanne Schnittger, et al.
Blood
|
May 16, 2009
Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
Ken I Mills, Alexander Kohlmann, P Mickey Williams, et al.
Blood
|
August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutations
Vera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
Journal of Cancer Research and Clinical Oncology
|
November 5, 2014
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
Katerina Machova Polakova, Vojtech Kulvait, Adela Benesova, et al.
Plos One
|
April 9, 2024
Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes
Theresa May, Michelle S Clement, Harkanwal Halait, et al.
ESMO Open
|
October 12, 2017
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
James L Sherwood, Helen Brown, Alessandro Rettino, et al.
Leukemia Research
|
February 22, 2017
A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts
Kamila Janusz, Mónica Del Rey, María Abáigar, et al.
The Journal of Molecular Diagnostics : JMD
|
November 19, 2023
Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non-Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic
Jhanelle E Gray, Ji-Youn Han, Aino Telaranta-Keerie, et al.
Nature Communications
|
January 15, 2015
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan, Deepika Kanojia, Jia Li, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Blood
|
August 25, 2012
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Blood
|
May 12, 2009
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
Claudia Haferlach, Cristina Mecucci, Susanne Schnittger, et al.
Blood
|
May 16, 2009
Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
Ken I Mills, Alexander Kohlmann, P Mickey Williams, et al.
Blood
|
August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutations
Vera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
Journal of Cancer Research and Clinical Oncology
|
November 5, 2014
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
Katerina Machova Polakova, Vojtech Kulvait, Adela Benesova, et al.
Plos One
|
April 9, 2024
Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes
Theresa May, Michelle S Clement, Harkanwal Halait, et al.
ESMO Open
|
October 12, 2017
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
James L Sherwood, Helen Brown, Alessandro Rettino, et al.
Leukemia Research
|
February 22, 2017
A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts
Kamila Janusz, Mónica Del Rey, María Abáigar, et al.
The Journal of Molecular Diagnostics : JMD
|
November 19, 2023
Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non-Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic
Jhanelle E Gray, Ji-Youn Han, Aino Telaranta-Keerie, et al.
Nature Communications
|
January 15, 2015
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan, Deepika Kanojia, Jia Li, et al.
Page
of 11